Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
Senate Majority Leader Mitch McConnell’s insistence that legal liability protections for businesses, schools and colleges be included in any new coronavirus relief bill is approaching a moment of reckoning.
Speaker Nancy Pelosi (D-Calif.) said Sunday that “of course there’s room for compromise” on the now-expired $600-per-week unemployment benefit Democrats have advocated keeping.
The world’s biggest drug makers and their trade groups have cut checks to 356 lawmakers ahead of this year’s election — more than two-thirds of the sitting members of Congress, according to a new STAT analysis.
Racked with anxiety, Lauren Shell needed to talk to her cancer doctor. But she lives at least an hour away and it was the middle of her workday. It was also the middle of a pandemic. Enter telemedicine.
The Trump administration released a long-awaited proposal to change how their star ratings posted on the Hospital Compare website are calculated, saying they aim to make the new methodology simpler and address concerns held by the industry about the scoring.
White House officials have begun looking at unspent money from Cares Act to see if it can be repurposed for unemployment aid and other initiatives
Independent insurance agents have a unique tool in their toolkit when it comes to helping small businesses through the COVID-19 pandemic. They have the advantage of true empathy. Why? Because the vast majority of agencies in the United States are small businesses themselves.
Telehealth giant Teladoc is acquiring virtual care company Livongo in a deal valued at $18.5 billion.
Providers say there are a number of logistical, regulatory and educational hurdles that must be overcome for telehealth to reach its potential.
Moderna will charge between $32 and $37 a dose for its experimental coronavirus vaccine for some "low volume" customers, the company's CEO said Wednesday